Filter
1137
Filtered Results: 1137
Text search:
antibodies
Featured
Recommendations
149
New Publications
286
Language
Document type
No document type
565
Guidelines
239
Studies & Reports
140
Manuals
60
Fact sheets
56
Strategic & Response Plan
27
Training Material
20
Situation Updates
10
Brochures
6
Resource Platforms
5
Infographics
4
Videos
4
App
1
Countries / Regions
India
93
Global
53
Nigeria
23
Nepal
22
Latin America and the Carribbean
21
South Africa
20
Tanzania
18
Philippines
16
Africa
15
Indonesia
14
Kenya
13
Middle East and North Africa
13
Western and Central Europe
13
Germany
12
Russia
12
Ethiopia
12
Liberia
12
Syria
11
Brazil
11
Sierra Leone
10
Malawi
10
West and Central Africa
10
East and Southern Africa
10
Uganda
10
Rwanda
9
Zambia
9
Congo, Democratic Republic of
7
Eastern Europe
7
Myanmar / Burma
7
Venezuela
6
Bangladesh
6
Namibia
6
Colombia
5
Ukraine
5
Yemen
5
Burkina Faso
4
Afghanistan
4
Peru
4
Guinea
4
South–East Asia Region
4
Pakistan
4
Lesotho
3
Turkey
3
Cameroon
3
Zimbabwe
3
Mozambique
3
USA
3
Cambodia
3
Asia
3
Saudi Arabia
3
Spain
3
Lebanon
3
Mali
3
South Sudan
3
Ecuador
3
Mexico
2
Ghana
2
Senegal
2
Niger
2
Qatar
2
Haiti
2
Jordan
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
France
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Argentina
2
Vietnam
2
Egypt
2
Sudan
2
Georgia
2
Chad
2
Libya
2
Botswana
2
Iraq
2
Somalia
2
Madagascar
2
Eswatini/ Swaziland
2
North Macedonia
1
Tajikistan
1
El Salvador
1
Serbia
1
Benin
1
Togo
1
China
1
Kazakhstan
1
Chile
1
Iran
1
Congo-Brazzaville
1
Uzbekistan
1
Morocco
1
Mauritania
1
Armenia
1
Dominican Republic
1
Western Pacific Region
1
Jamaica
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Southern Africa
1
Papua New Guinea
1
Nicaragua
1
Moldova
1
Sri Lanka
1
Djibouti
1
Palestine
1
Poland
1
Honduras
1
Angola
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
369
Clinical Guidelines
176
Public Health
48
Women & Child Health
44
Pharmacy & Technologies
41
Capacity Building
26
Key Resources
16
Toolboxes
COVID-19
215
HIV
119
NTDs
88
Rapid Response
70
Ebola
47
TB
35
Zika
35
Refugee
23
Mental Health
21
Pharmacy
20
NCDs
20
Caregiver
16
Planetary Health
13
Polio
13
AMR
12
Cholera
6
Natural Hazards
4
Conflict
4
Health Financing Toolbox
3
Specific Hazards
2
Disability
2
Global Health Education
2
The number of confirmed COVID-19 cases detected and reported in each country is influenced by
many factors including limited access and/or utilization of healthcare and COVID-19 testing, limited
surveillance, lack of knowledge amongst the population about when to seek testing, an asymptomatic pres...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
16 Dec. 2020
This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests to COVID-19 testing. The guidance serves as reference for policymakers, laboratory leads, implementing...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity and mortality in children < 5 years of agehgenerate data to inform vaccine schedule and delivery strategy decisions to op...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
February 2021.
Improving our response to the ongoing COVID-19 pandemic in Africa requires regularly updated information, constant innovation, and considerable support towards research and development (R&D) for priorities that respond to the African realities. Shaping the research agenda and stimula...
1 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
21 августа 2020 г.
В этом документе представлены рекомендации для лиц, принимающих решения, работников общественного
здравоохранения и специалистов в области педиа...
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current COVID-19 pandemic. It also advises on the use of medical masks for children under certain conditions.
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK.
This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will b...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
